Bill Title: Amends the Prior Authorization Reform Act. Provides that notwithstanding any other provision of law, a health insurance issuer or a contracted utilization review organization may not require a prior authorization for drug therapies approved by the U.S. Food and Drug Administration for the treatment of hereditary bleeding disorders any more frequently than 6 months or the length of time the prescription for that dosage remains valid, whichever period is shorter. Effective January 1, 2026.

Spectrum: Moderate Partisan Bill (Republican 9-1)

Status: (Passed) 2024-07-19 - Public Act . . . . . . . . . 103-0659 [HB4055 Detail]

Text: Latest bill text (Chaptered) [HTML]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2023 Illinois HB4055 at this time.

Social Comments on IL HB4055